Atlas

FDA-Inspected Site

Venus Pharmaceuticals International, Inc.

4 FDA inspections are on record for Venus Pharmaceuticals International, Inc. in Hauppauge, United States.

483· Form 483 issued

Hauppauge, United States · Last updated July 11, 2026

Overview

  • 4 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2013-02-25.

At a glance

Inspections

4

Form 483s

4

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Feb 2013 – 25 Feb 2013Foods & Cosmetics483View 483 →
20 Jan 2012Not recorded483View 483 →
12 Jul 2011Not recorded483View 483 →
19 Aug 2010Not recordedWLView 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

25 Feb 2013
n/a

Procedural requirements

Cited by Valerie A Potopsingh

20 Jan 2012
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Meredith P Soehl

20 Jan 2012
21 CFR 111.75(a)(2)(ii)(A)

Component - qualify supplier

Cited by Meredith P Soehl

20 Jan 2012
21 CFR 111.75(c)

Specifications met - verify; finished batch

Cited by Meredith P Soehl

20 Jan 2012
21 CFR 111.123(b)(2)

Quality control - batch, product specifications

Cited by Meredith P Soehl

Investigators

FDA investigators tied to this site in the record.

Meredith P Soehl2 insp.
Valerie A Potopsingh1 insp.
Stephanie Durso1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations3x
21 CFR 111.75(c)Cited across public-safe Form 483 observations3x
21 CFR 111.103Cited across public-safe Form 483 observations2x
21 CFR 111.155(e)Cited across public-safe Form 483 observations2x
21 CFR 111.160(c)(3)Cited across public-safe Form 483 observations2x
21 CFR 111.205(a)Cited across public-safe Form 483 observations2x
21 CFR 111.303Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations2x
21 CFR 110.40(a)Cited across public-safe Form 483 observations1x
21 CFR 111.123(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.14(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.160(c)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.23(b)Cited across public-safe Form 483 observations1x
21 CFR 111.25(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(b)Cited across public-safe Form 483 observations1x
21 CFR 111.260(c)Cited across public-safe Form 483 observations1x
21 CFR 111.27(b)Cited across public-safe Form 483 observations1x
21 CFR 111.320(b)Cited across public-safe Form 483 observations1x
21 CFR 111.325(b)(2)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.365(a)Cited across public-safe Form 483 observations1x
21 CFR 111.430(b)Cited across public-safe Form 483 observations1x
21 CFR 111.503Cited across public-safe Form 483 observations1x
21 CFR 111.570(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.605Cited across public-safe Form 483 observations1x
21 CFR 111.77(a)Cited across public-safe Form 483 observations1x
n/aCited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Venus Pharmaceuticals International, Inc.'s 4 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat